Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including other brain neurons; strongest in retinal horizontal cells | 0.75 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 39 Parkinson's papers of 309 | 0.52 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 9283
Sealed predictions
- IGLON5 in dopamine neurons, braak+0.02 (p 0.964) → +0.00 (p 1.000)receipt 9290
Swarm cases
receipt 9290: IGLON5 in dopamine neurons, braak
- power
- full sample -0.03 (p 0.922, n 18), 95% CI -0.49 to +0.45. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.03 (p 0.922, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.01 (p 0.956, n 18). could be the mix.
- skeptic
- leave-one-out range -0.13 to +0.09, sign flips 6; without severely affected donors -0.03 (p 0.922, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for IGLON5 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts